HER2 expression and efficacy of T-DM1

par Montemurro, Filippo
Publié dans Breast Cancer Res (2014)

Does immediate reconstruction increase postmastectomy surgical site infection?

par Carlucci, Salvatore, Montemurro, Filippo, Ponzone, Riccardo
Publié 2012

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

par Geuna, Elena, Montemurro, Filippo, Aglietta, Massimo, Valabrega, Giorgio
Publié 2012

Role of trastuzumab in the management of HER2-positive metastatic breast cancer

par Milani, Andrea, Montemurro, Filippo, Gioeni, Luisa, Aglietta, Massimo, Valabrega, Giorgio
Publié 2010

The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer

par Chilà, Giovanna, Guarini, Vincenzo, Galizia, Danilo, Geuna, Elena, Montemurro, Filippo
Publié dans Drug Des Devel Ther (2021)

Clinical utility of exemestane in the treatment of breast cancer

par Zucchini, Giorgia, Geuna, Elena, Milani, Andrea, Aversa, Caterina, Martinello, Rossella, Montemurro, Filippo
Publié dans Int J Womens Health (2015)

A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features

par Giannini, Valentina, Mazzetti, Simone, Marmo, Agnese, Montemurro, Filippo, Regge, Daniele, Martincich, Laura
Publié dans Br J Radiol (2017)

AKT signaling in ERBB2-amplified breast cancer

par Carmona, F Javier, Montemurro, Filippo, Kannan, Srinivasaraghavan, Rossi, Valentina, Verma, Chandra, Baselga, José, Scaltriti, Maurizio
Publié dans Pharmacol Ther (2015)

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)

par Di Maio, Massimo, Bruzzi, Paolo, Perrone, Francesco, Torri, Valter, Montemurro, Filippo, Tiseo, Marcello, Vasile, Enrico
Publié dans ESMO Open (2016)

Trastuzumab Beyond Progression in Retrospective Analyses: An Issue of Equal Opportunities

par Montemurro, Filippo, Redana, Stefania, Geuna, Elena, Milani, Andrea, Rossi, Valentina, Martinello, Rossella, Valabrega, Giorgio, Aglietta, Massimo
Publié 2011

“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”?

par Kolling, Stefan, Ventre, Ferdinando, Geuna, Elena, Milan, Melissa, Pisacane, Alberto, Boccaccio, Carla, Sapino, Anna, Montemurro, Filippo
Publié dans Front Oncol (2020)

Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study

par Montemurro, Filippo, Redana, Stefania, Nolè, Franco, Donadio, Michela, Jacomuzzzi, Maria Elena, Valabrega, Giorgio, Viale, Giuseppe, Sapino, Anna, Aglietta, Massimo
Publié 2008

A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy

par Sottile, Antonino, Ortega, Cinzia, Berruti, Alfredo, Mangioni, Monica, Saponaro, Sara, Polo, Alessandra, Prati, Veronica, Muto, Giovanni, Aglietta, Massimo, Montemurro, Filippo
Publié 2012

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

par Redana, Stefania, Donadio, Michela, Nolè, Franco, Jacomuzzi, Maria Elena, Beano, Alessandra, Martinello, Rossella, Sapino, Anna, Viale, Giuseppe, Aglietta, Massimo, Montemurro, Filippo
Publié 2010

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer

par Peraldo-Neia, Caterina, Migliardi, Giorgia, Mello-Grand, Maurizia, Montemurro, Filippo, Segir, Raffaella, Pignochino, Ymera, Cavalloni, Giuliana, Torchio, Bruno, Mosso, Luciano, Chiorino, Giovanna, Aglietta, Massimo
Publié 2011

Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer

par Rossi, Valentina, Sarotto, Ivana, Maggiorotto, Furio, Berchialla, Paola, Kubatzki, Franziska, Tomasi, Nicoletta, Redana, Stefania, Martinello, Rossella, Valabrega, Giorgio, Aglietta, Massimo, Ponzone, Riccardo, Montemurro, Filippo
Publié 2012

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases

par Siravegna, Giulia, Geuna, Elena, Mussolin, Benedetta, Crisafulli, Giovanni, Bartolini, Alice, Galizia, Danilo, Casorzo, Laura, Sarotto, Ivana, Scaltriti, Maurizio, Sapino, Anna, Bardelli, Alberto, Montemurro, Filippo
Publié dans ESMO Open (2017)

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

par Benvenuti, Silvia, Milan, Melissa, Geuna, Elena, Pisacane, Alberto, Senetta, Rebecca, Gambardella, Gennaro, Stella, Giulia M, Montemurro, Filippo, Sapino, Anna, Boccaccio, Carla, Comoglio, Paolo M
Publié dans EMBO Mol Med (2020)

Potential biomarkers of long‐term benefit from single‐agent trastuzumab or lapatinib in HER2‐positive metastatic breast cancer

par Montemurro, Filippo, Prat, Aleix, Rossi, Valentina, Valabrega, Giorgio, Sperinde, Jeff, Peraldo-Neia, Caterina, Donadio, Michela, Galván, Patricia, Sapino, Anna, Aglietta, Massimo, Baselga, José, Scaltriti, Maurizio
Publié dans Mol Oncol (2013)

Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study

par Geuna, Elena, Lombardi, Pasquale, Martinello, Rossella, Garino, Davide, Bonzano, Alessandro, Galizia, Danilo, Nuzzo, Annamaria, Berchialla, Paola, Becco, Paolo, Mangioni, Monica, De Zarlo, Lorena, Montemurro, Filippo
Publié dans Cancers (Basel) (2020)